Clinical Trial Update: Evaluation of PSMA Antagonist Produced by Two Different Methods [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a PSMA antagonist produced by two different methods for metastatic prostate adenocarcinoma; trial completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma

Drugs mentioned

• PSMA antagonist (two production methods)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Metastatic Prostate Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-09-22